0.6290USD-0.16%Mkt Cap: 9.94M USDP/E: —Last update: 2026-05-22
CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora,…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Company
Market Cap9.94M USD
Enterprise Value8.26M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-29.56M USD
Revenue/Share—
Last Price0.6290 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees16
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.39
PEG—
EV/EBITDA-0.37
EV/Revenue—
P/S—
P/B-8.75
EPS (TTM)-1.31
EPS (Forward)-1.63
52W Range
0.46102% of range7.200
52W High7.200 USD
52W Low0.4610 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE445.14%
ROA-217.51%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-21.18M USD
CapEx (TTM)28.00K USD
FCF Margin—
FCF Yield—
Net Debt-1.46M USD
Net Debt/EBITDA0.07
Balance Sheet
Debt/Equity-1.46
Current Ratio1.61
Quick Ratio1.54
Book Value/Sh-0.0720 USD
Cash/Share0.5290 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.5 (Buy)
Target (Mean)10.33 USD
Target Range6.000 USD – 15.00 USD
# Analysts3
Ownership
Shares Out.15.80M
Float8.94M
Insiders14.35%
Institutions36.05%
Short Interest
Short Ratio0.9d
Short % Float3.48%
Short % Out.1.07%
Shares Short167.95K
Short (prev mo.)337.92K
Technical
SMA 500.6336 (-0.7%)
SMA 2002.560 (-75.4%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)132.56K
Avg Vol (10d)125.52K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—